Bildkälla: Stockfoto

Asarina Pharma: Discouraging Results in Menstrual Migraine - Redeye

Redeye reckons negative results in Menstrual Migraine (MM) and excludes this project from our valuation.

Redeye reckons negative results in Menstrual Migraine (MM) and excludes this project from our valuation.
Börsvärldens nyhetsbrev
ANNONSER